Search This Blog

Tuesday, August 6, 2019

Dova Pharmaceuticals EPS misses by $0.03, misses on revenue

Dova Pharmaceuticals (NASDAQ:DOVA): Q2 GAAP EPS of -$0.60 misses by $0.03.
Revenue of $3.52M (-23.1% Y/Y) misses by $2.05M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)